Skip to content
value.today

CardioInsight Technologies, Inc.

🇺🇸 Cleveland, Ohio, USABiotechnologyFounded 2006
Total raised
$17 M
3 rounds on record
Latest round
$8 M
Feb 2012
First round on record
Jan 2010
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CardioInsight Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2012$8 MNo. 3$2 to $10 million

CardioInsight Technologies, Inc.: Raise no. 3, Feb 2012

Investors in this round

14 investors had bought by the notice of May 22, 2012: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
$5,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$400,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charu Ramanathan · Executive Officer
  • Kevin Mendelsohn · Executive Officer
  • James Bullock · Director
  • Jay Katarincic · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Nealis, Attorney. Source: SEC Form D, newest notice filed May 22, 2012. Read the notice at the SEC.

equitySEC
Dec 2010$2 MNo. 2Under $2 million

CardioInsight Technologies, Inc.: Raise no. 2, Dec 2010

Investors in this round

7 investors had bought by the notice of Dec 16, 2011: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$200,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charu Ramanathan · Executive Officer
  • James Bullock · Executive Officer
  • Steven Arless · Executive Officer, Director
  • Jay Katarincic · Director
  • Michael Haag · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Nealis, Attorney. Source: SEC Form D, newest notice filed Dec 16, 2011. Read the notice at the SEC.

equitySEC
Jan 2010$8 MNo. 1$2 to $10 million

CardioInsight Technologies, Inc.: Raise no. 1, Jan 2010

Investors in this round

8 investors had bought by the notice of Dec 16, 2011: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
$5,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$200,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charu G. Ramanathan · Executive Officer
  • James G. Bullock · Executive Officer
  • Steven G. Arless · Executive Officer, Director
  • Jay G. Katarincic · Director
  • Michael G. Haag · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Nealis, Attorney. Source: SEC Form D and 1 amendment, newest notice filed Dec 16, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CardioInsight Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (May 2012).

    SEC Form D · May 2012

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2012

That is all the official record says: CardioInsight Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of CardioInsight Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 14 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CardioInsight Technologies, Inc.
NameRoleNamed in
Charu RamanathanExecutive officerMay 2012
Kevin MendelsohnExecutive officerMay 2012
Charu G. RamanathanExecutive officerDec 2011
James BullockExecutive officerDec 2011
James G. BullockExecutive officerDec 2011
Steven ArlessExecutive officerDec 2011
Steven G. ArlessExecutive officerDec 2011
Harold G. WodlingerExecutive officerJan 2010
James BullockDirectorMay 2012
Jay KatarincicDirectorMay 2012
Jay G. KatarincicDirectorDec 2011
Michael G. HaagDirectorDec 2011
Michael HaagDirectorDec 2011
Steven ArlessDirectorDec 2011
Steven G. ArlessDirectorDec 2011
Charu G. RamanathanDirectorJan 2010